Rani Therapeutics promotes Alireza Javadi to chief technical officer Jan 28, 2026 07:01AM
Rani Therapeutics Holdings, Inc. (RANI) Tops Q3 EPS by 5c Nov 6, 2025 06:22PM
RANI Therapeutics secures $1.085 billion Chugai deal and $60.3 million funding Nov 6, 2025 04:33PM
H.C. Wainwright Assumes Rani Therapeutics Holdsing s (RANI) at Buy Oct 21, 2025 06:09AM
Rani Therapeutics secures $1.085 billion collaboration deal with Chugai Oct 17, 2025 07:30AM


Aug 8, 2025 04:09PM Rani Therapeutics (RANI) Files $200M Mixed Shelf
Aug 7, 2025 04:23PM Rani Therapeutics Holdings, Inc. (RANI) Tops Q2 EPS by 11c
Jul 15, 2025 09:01AM Rani Therapeutics prices $3 million registered direct offering at $0.40 per share
May 19, 2025 08:01AM Rani Therapeutics (RANI) Announces Research Agreement with Chugai
May 16, 2025 12:17AM Rani Therapeutics Holdsing s (RANI) PT Lowered to $4 at Oppenheimer
May 13, 2025 04:14PM Rani Therapeutics Holdings, Inc. (RANI) Tops Q1 EPS by 2c
Apr 1, 2025 09:23AM Stifel Reiterates Buy Rating on Rani Therapeutics Holdsing s (RANI)
Apr 1, 2025 04:54AM BTIG Reiterates Buy Rating on Rani Therapeutics Holdsing s (RANI)
Mar 31, 2025 04:07PM Rani Therapeutics Holdings, Inc. (RANI) Misses Q4 EPS by 1c
Mar 27, 2025 07:52AM Stifel Reiterates Buy Rating on Rani Therapeutics Holdsing (RANI)
Mar 26, 2025 04:06PM Rani Therapeutics (RANI) Announces Preclinical Data Demonstrating Bioequivalence of RT-114
Mar 26, 2025 04:55AM BTIG Reiterates Buy Rating on Rani Therapeutics Holdsing s (RANI)
Feb 5, 2025 04:30PM Rani Therapeutics (RANI) Announces Preclinical Data Demonstrating Successful Oral Delivery of Semaglutide via RaniPill® HC
Nov 14, 2024 05:22PM Rani Therapeutics Holdings, Inc. (RANI) Tops Q3 EPS by 5c
Oct 18, 2024 06:46AM H.C. Wainwright Reiterates Buy Rating on Rani Therapeutics Holdsing s (RANI)
Oct 17, 2024 08:04AM Rani Therapeutics (RANI) Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin Triagonist
Oct 15, 2024 08:31AM Rani Therapeutics (RANI) Prices $10M Share and Warrant Offering at $3/sh, Cancels Certain Existing Warrants
Aug 16, 2024 06:43AM Rani Therapeutics Holdsing s (RANI) PT Lowered to $9 at H.C. Wainwright
Jul 22, 2024 08:31AM Rani Therapeutics (RANI) Prices 2.8M Share Offering at $3.08/sh Registered Direct Offering
Jun 24, 2024 03:10PM Stifel Reiterates Buy Rating on Rani Therapeutics Holdsing s (RANI)
Jun 24, 2024 07:04AM Rani Therapeutics Announces (RANI) Partnership with ProGen on Development of Oral Obesity Treatment